$32.26 Million in Sales Expected for Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) This Quarter
Wall Street brokerages expect Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Rating) to post $32.26 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for Intra-Cellular Therapies’ earnings, with the highest sales estimate coming in at $32.50 million and the lowest estimate coming in at $32.08 million. […]